Literature DB >> 7083486

Cholinergic mechanism in the large cat cerebral artery.

T J Lee.   

Abstract

The isolated cat cerebral arteries (basilar, middle cerebral, anterior cerebral, and internal carotid) were studied in vitro. ACh at low concentration (3 x 10(-8) to 3 x 10(-6) M) induced relaxation, and at high concentration (10(-5) to 3 x 10(-3) M) induced constriction of the arteries with endothelial cells. In contrast, concentration of any magnitude (10(-6) to 3 x 10(-3) M) induced constriction exclusively in arteries without endothelium. Atropine (3 x 10(-6) to 3 x 10(-5) M) blocked and physostigmine (3 x 10(-6) M) potentiated both ACh-induced relaxation and constriction. These results suggest that the relaxation induced by exogenous ACh is solely dependent on the endothelial cells and that the primary effect of the direct action of ACh on the smooth muscle cells is constriction. Transmural nerve stimulation (TNS) induced a frequency-dependent relaxation in the arteries with or without endothelium. Neither atropine nor physostigmine affected the TNS-induced dilator response in either preparation. This, together with the wide separation between the nerve and endothelium in the vessel wall, suggests that ACh is not involved in TNS-induced vasodilation. Furthermore, the TNS-induced relaxation at any frequency is not smaller but greater in the arteries without endothelial cells than in those with endothelial cells. Blockade of the TNS-induced vasodilation by tetrodotoxin (TTX) or cold storage denervation did not prevent the arteries from relaxing in response to ACh or methacholine (MCh). It is suggested that the TNS-induced vasodilation is independent of the endothelial cells and that the vasodilation is due to the direct action of a yet-to-be identified dilator transmitter on the smooth muscle cells. Results of the present study support our previous finding that, in the cat cerebral artery. ACh is more likely to be a constrictor transmitter than a dilator transmitter.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7083486     DOI: 10.1161/01.res.50.6.870

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  8 in total

1.  Reactive changes in adrenal innervation of cerebral arteries in conditions of the activation of cholinergic mechanisms.

Authors:  A P Pugovkin; S G Lazarev
Journal:  Neurosci Behav Physiol       Date:  1992 Jul-Aug

2.  Effects of capsaicin on vascular smooth muscle.

Authors:  S P Duckles
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-05       Impact factor: 3.000

3.  Evidence for two separate vasoconstriction-mediating nucleotide receptors, both distinct from the P2x-receptor, in rabbit basilar artery: a receptor for pyrimidine nucleotides and a receptor for purine nucleotides.

Authors:  I von Kügelgen; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

4.  Ginsenosides-induced nitric oxide-mediated relaxation of the rabbit corpus cavernosum.

Authors:  X Chen; T J Lee
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

5.  Influence of prostaglandin-synthesis inhibitors on carbachol- and histamine-induced vasodilatation in perfused rat hindquarters.

Authors:  J Van de Voorde; I Leusen
Journal:  Pflugers Arch       Date:  1983-06-01       Impact factor: 3.657

6.  Responses of isolated and perfused dog coronary arteries to acetylcholine, norepinephrine, KCl, and diltiazem before and after removal of the endothelial cells by saponin.

Authors:  T Nakane; N Itoh; S Chiba
Journal:  Heart Vessels       Date:  1986       Impact factor: 2.037

7.  In vivo effect of visible light on feline cortical microcirculation.

Authors:  H Bertalanffy; T Kawase; S Toya
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

8.  Heterogeneous vasomotor responses of anatomically distinct feline cerebral arteries.

Authors:  E Hamel; L Edvinsson; E T MacKenzie
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.